CLOVER HEALTH INVESTMENTS, CORP. current report, 17 May 2021

Full document

Clover Health Investments, Corp. Form 8-K Summary

Business Context and Reporting Period

Clover Health Investments, Corp. filed a Current Report on Form 8-K dated May 17, 2021. The filing announces the Company’s financial results for the quarter ended March 31, 2021. The detailed results were issued in a press release furnished as Exhibit 99.1, but the press release text is not included in the provided filing content.

Financial Performance and Key Metrics

  • Revenue, profit or loss, cash flow, margins, debt, liquidity, membership, and other financial metrics are not provided in the filing text supplied.
  • The filing states only that the Company released financial results for the quarter ended March 31, 2021.
  • The filing does not provide a clear comparison with the prior comparable period.

Material Changes Versus the Prior Comparable Period

The filing text does not describe material period-over-period changes. Any such information would likely be contained in Exhibit 99.1, which is referenced but not reproduced in the supplied content.

Guidance, Outlook, Risks, and Unusual Items

  • No financial guidance, outlook, management commentary, contingencies, or unusual items are stated in the provided filing text.
  • The Company notes that it communicates material information through SEC filings, press releases, public conference calls, presentations, webcasts, its investor-relations website, and certain social-media channels.
  • Information posted on social-media channels is not incorporated by reference into this report or other SEC filings.
  • The results announcement under Item 2.02 and the related exhibit are furnished, rather than filed, for purposes of Section 18 of the Exchange Act, except where expressly incorporated by reference.

Key Facts for Investors to Verify

  1. Obtain and review Exhibit 99.1 for the quarter ended March 31, 2021, including revenue, net income or loss, operating metrics, cash flow, liquidity, and guidance.
  2. Verify any reported results against the Company’s subsequent quarterly or annual SEC filings.
  3. Review management’s discussion of medical costs, membership trends, risk adjustment, operating expenses, and cash requirements, as these details are not included in the supplied filing text.
  4. Note that the Company’s Class A common stock traded under “CLOV” and its redeemable warrants under “CLOVW” on Nasdaq as of the filing date.